12 Sep, 2019 image
search_img

Global Telehealth is On the Rise

By Nina Deka, Senior Research Analyst, ROBO Global

The National Healthcare Security Administration of China issued its anticipated guidelines on pricing and insurance coverage for internet medical services, marking a significant milestone for telemedicine adoption in China. This news is in line with our view that global telehealth adoption is accelerating, and is a positive catalyst for the ROBO Global Healthcare Technology and Innovation Index (HTEC). Ping An Healthcare and Technology Company, a member of HTEC, is the market leader for telemedicine services in China, and well positioned for this trend.

New reimbursement policies should accelerate telemedicine adoption

The NHSA is a national agency in China that oversees state-backed health insurance plans. It recently issued new guidelines that specify what type of online medical services are considered legally reimbursable, such as consultations through which a doctor can diagnose and prescribe treatment for certain acute or chronic illnesses. The guidelines also require local governments to coordinate reimbursement policies within the scope of their responsibility. This means that local governments will begin to provide reimbursement coverage for internet medical services, such as those provided by Ping An (e.g. medical consults, diagnosis, prescription drug delivery). We expect local governments to gradually enact new policies over time, and as each region goes live, it will accelerate adoption for telemedicine among its providers. The provider value proposition is clear. They will not only get paid for online visits, but they will also be able to expand their reach, particularly to patients who live in rural areas.

Ping An is particularly well positioned for this trend

We recently discussed telemedicine and the growth we’re seeing with US-based Teladoc, another member of the HTEC Index. The need for better healthcare access is a global issue, and China is another example of a market that sees telemedicine as a solution. Ping An is a market leader in China and is already well-positioned for this trend. The company has 289 million registered users, and conducts 656,000 medical consultations per day. Ping An also has a license to operate in three local governments, and is currently in discussions with more. It has also partnered with 50 hospitals across China to jointly construct internet hospitals. We believe that as the reimbursement environment improves, demand for Ping An’s services will increase, and growth could further accelerate.

Ping An is a one-stop portal to the entire healthcare ecosystem

Ping An uses an AI-assisted integrated technology platform, an in-house medical team, and a network of healthcare providers to provide online medical services to patients in the family doctor and consumer markets. It also has a Health Mall that sells medicine, supplements, and medical devices. Beyond “sick care,” Ping An also offers personalized wellness programs.

AI Doctor is at the core of Ping An’s platform

Ping An recently showcased nine AI-driven products at the 2019 World AI Conference. The one that got the most attention was AI Doctor, which utilizes artificial intelligence to assist the company’s physicians with diagnosis. It covers over 3,000 diseases, and is continuously trained with 530 million consultation records. The system doesn’t replace doctors. It actually improves the speed and efficiency of their diagnostic process. In addition to Ping An’s own medical team, 150 hospital customers are using AI Doctor today.

  • 825 Followers
  • Subscribeto RSS Feed

Popular & Recent News

Recent White Papers

Categories

You are now leaving the ROBO Global website

You are now leaving the ROBO Global website. The following landing page may contain information concerning investments, products or other information. Exchange Traded Concepts LLC, the Fund Advisor are not responsible for the accuracy or completeness of information on non-affiliated websites. The material available on non-affiliated websites has been produced by the entities that are not affiliated with Exchange Traded Concepts LLC. Descriptions of, references to, or links to products or publications within any non-affiliated linked website does not imply endorsement of that product or publication by Exchange Traded Concepts LLC. Any opinions or recommendations from non-affiliated websites are solely those of the independent providers and are not the opinions or recommendations of Exchange Traded Concepts LLC, which is not responsible for any inaccuracies or errors.

Proceed

Dismiss

You are now leaving the ROBO Global website

You are now leaving the ROBO Global, LLC website and being directed to ETF Securities (UK) Limited which is authorized and regulated by the United Kingdom Financial Conduct Authority (the “FCA”). By clicking “OK”, you acknowledge that you are someone authorized to undertake investment activities relating to the Exchange Traded Funds (ETFs). IN addition, you understand that ROBO Global, LLC is not making any financial promotion or carrying out any regulated activity of said products. The following landing page may contain information concerning investments, products or other information. ETF Securities (UK) Limited is not responsible for the accuracy or completeness of information on non-affiliated websites. The material available on non-affiliated websites has been produced by entities that are not affiliated with ETF Securities (UK) Limited. Descriptions of references to, or links to products or publications within any non-affiliated linked websites does not imply endorsement of that product or publication by ETF Securities (UK) Limited. Any opinions or recommendations from non-affiliated websites are solely those of the independent providers and are not the opinions or recommendations of ETF Securities (UK) Limited, which is not responsible for any inaccuracies or errors.

Proceed

Dismiss

You are now leaving the ROBO Global website

You are now leaving the ROBO Global, LLC website and being directed to ETFS Management (AUS) Limited which is authorized and regulated by the Australian Securities and Investments Commission (“ASIC“). By clicking “OK”, you acknowledge that you are someone authorized to undertake investment activities relating to the Exchange Traded Funds (ETFs). In addition, you understand that ROBO Global, LLC is not making any financial promotion or carrying out any regulated activity of said products. The following landing page may contain information concerning investments, products or other information. ETFS Management (AUS) Limited is not responsible for the accuracy or completeness of information on non-affiliated websites. The material available on non-affiliated websites has been produced by entities that are not affiliated with ETFS Management (AUS) Limited. Descriptions of references to, or links to products or publications within any non-affiliated linked websites does not imply endorsement of that product or publication by ETFS Management (AUS) Limited. Any opinions or recommendations from non-affiliated websites are solely those of the independent providers and are not the opinions or recommendations of ETFS Management (AUS) Limited, which is not responsible for any inaccuracies or errors.

Proceed

Dismiss